QuiverFunds QUIVERFUNDS SUBSCRIBE

BLOG

Analysis & Perspectives

Venture capital, startup fundraising, IPOs, M&A and the deals moving the markets.

26 SEPT 2026

ADARx Pharmaceuticals nets $446 million in IPO, aiming to innovate RNAi therapies

ADARx Pharmaceuticals raises $446M in its IPO, positioning itself for breakthroughs in RNAi-based therapies.

Read article →
26 SEPT 2026

First Solar faces headwinds as rising borrowing costs impact solar sector

Solar stocks decline led by First Solar due to high borrowing costs impacting project financing.

Read article →
26 SEPT 2026

SoftBank's Carro considers pioneering dual listing on Nasdaq and SGX

Carro, backed by SoftBank, eyes first-ever dual IPO on Nasdaq and SGX to expand its market reach.

Read article →
26 SEPT 2026

MGM Resorts shares tumble as People Inc. retracts takeover proposal

MGM Resorts' stock drops significantly following People Inc.'s withdrawal of its acquisition bid.

Read article →
25 SEPT 2026

China's self-sufficiency reshapes trade dynamics with the U.S.

China's push for self-sufficiency is reshaping the trade landscape with the U.S., posing new challenges and opportunities amid ongoing tensions.

Read article →
25 SEPT 2026

Earnings surprises: companies outperform predictions more than expected

Companies exceeded earnings estimates 75.9%. Analysts predict an average of 43.9%.

Read article →
25 SEPT 2026

U.S. Treasury auction attracts highest yields since 2024

U.S. Treasury's two-year auction draws investor interest with the highest yield seen since 2024.

Read article →
25 SEPT 2026

Inflation concerns loom as Fed considers rate hike ahead of elections

Inflation pressures heighten the chance of a Fed rate hike as elections approach, leading to market shifts and economic implications.

Read article →
25 SEPT 2026

GRAIL's Galleri blood test receives FDA panel support for early cancer detection

GRAIL's Galleri test gains FDA panel endorsement for its effectiveness in early cancer detection.

Read article →